Boston Scientific Corp (BSX): Long-Term Debt
Older than the company's other figures. The latest Long-Term Debt is for the year ended 2017-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$3.81B
As of 2017-12-31
-3.2%
3-year compound annual growth
-1.9%
5-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2017-12-31 | $3.81B | -29.6% | 2018-02-20, Balance as of period end |
| 2016-12-31 | $5.42B | -4.1% | 2018-02-20, Balance as of period end |
| 2015-12-31 | $5.65B | +34.5% | 2016-02-24, Balance as of period end |
| 2014-12-31 | $4.20B | 0.0% | 2015-02-25, Balance as of period end |
| 2013-12-31 | $4.20B | 0.0% | 2014-02-26, Balance as of period end |
| 2012-12-31 | $4.20B | 0.0% | 2013-02-22, Balance as of period end |
| 2011-12-31 | $4.20B | -22.9% | 2012-02-17, Balance as of period end |
| 2010-12-31 | $5.45B | n/a | 2011-02-17, Balance as of period end |